The Gross Margin of Can Fite Biopharma Ltd (CANF.TA) is 90.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 90.62% |
2023-12-31 | 97.54% |
2022-12-31 | 97.64% |
2021-12-31 | 90.62% |
2020-12-31 | 70.30% |
2019-12-31 | 33.13% |